29 |
Systematic review: 1 [44] |
Non-medical: 5 [129, 147, 153, 162] |
Non-industry: 21 [20, 95, 102, 103, 106, 109, 113, 116, 124, 128, 129, 132, 134, 135, 139, 143, 146, 147, 153, 162] |
RCTs: 1 [20] |
Mixed use: 10 [4, 100, 104, 106, 107, 109, 116, 132, 135, 144] |
Mixed (industry and non-industry): 1 [96] |
Prospective cohort: 1 [96] |
Immediate effects in lab: 1 [20] |
Not funded: 2 [104, 107] |
Retrospective cohort: 2 [103, 135] |
Not reported: 11 [95, 102, 103, 105, 113, 124, 128, 134, 139, 143, 146] |
Not reported: 4 [4, 100, 105, 144] |
Case-control: 2 [129, 147] |
Sequential: 11 [4, 102, 104, 105, 116, 124, 128, 134, 139, 144, 146] |
Cross-sectional: 11 [95, 100, 106, 107, 109, 113, 132, 143, 153, 162] |